Germany
DEEurope
Regulatory Overview
Germany is regulated by the BfArM (Federal Institute for Drugs and Medical Devices). The country has 2 documented regulatory pathways for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.
Regulatory Authority
BfArM (Federal Institute for Drugs and Medical Devices)
Regulatory Pathways (2)
Compassionate use under §21a of the German Medicinal Products Act (AMG), authorised by BfArM for patients with serious or life-threatening diseases who cannot be adequately treated with authorised medicines.
EMA Article 83 compassionate use framework allowing access to unauthorised medicinal products for groups of patients with a chronically or seriously debilitating or life-threatening disease in Germany.
Drugs Available (232)
| ISO Code | DE |
| Region | Europe |
| Regulatory Authority | BfArM (Federal Institute for Drugs and Medical Devices) |
| Pathways | 2 documented |
| Drugs Available | 232 drug(s) |